Knight Jeff E. 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Jun 28, 2024
Insider Transaction Report
Form 4
Knight Jeff E.
Chief Operating Officer
Transactions
- Sale
Common Stock
2024-06-26$44.38/sh−956$42,427→ 52,580 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]Includes 956 shares acquired under the Issuer's Employee Stock Purchase Plan.